Trial Profile
Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Enoxaparin sodium
- Indications Stroke
- Focus Pharmacodynamics
- Acronyms ENCHASE
- 02 Jul 2018 New trial record